Glanzmann Thrombasthenia, Sutacimig, Hematology, Rare Diseases, Prophylaxis

Glanzmann Thrombasthenia, Sutacimig, Hematology, Rare Diseases, Prophylaxis

Sutacimig in Glanzmann Thrombasthenia: From Reactive Rescue to Subcutaneous Prophylaxis

Phase 2 data from HMB-001-CL101 positions sutacimig as a viable prophylactic standard of care, with particular relevance for the alloimmunized subpopulation where current options have effectively run out. See Disclaimer below * Glanzmann Thrombasthenia (GT) is an ultra-rare autosomal recessive bleeding disorder caused by a genetic deficiency or dysfunction in the